Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02607098 · ClinicalTrials.gov registry record
Understanding Adaptive Challenges Associated With Male-factor Infertility
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 24
- Enrollment target
NCT02607098: Completed study, sponsored by Duke University.
NCT02607098 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02607098 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the experience of men and their partners when diagnosed with male-factor infertility while trying to achieve a pregnancy and the skills they use to adapt to this diagnosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-11 |
What the finished NCT02607098 record still lists
NCT02607098 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02607098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02607098 about?
NCT02607098 is a clinical study titled "Understanding Adaptive Challenges Associated With Male-factor Infertility". The purpose of this study is to understand the experience of men and their partners when diagnosed with male-factor infertility while trying to achieve a pregnancy and the skills they use to adapt to this diagnosis.
What is the current status of trial NCT02607098?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2015-11. Estimated completion is 2016-11.
Who is sponsoring clinical trial NCT02607098?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia